SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-003227
Filing Date
2023-02-01
Accepted
2023-02-01 06:02:39
Documents
1
Period of Report
2023-01-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3986
  Complete submission text file 0001493152-23-003227.txt   5609
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2355 MAIN STREET SUITE 120 IRVINE CA 92614
Business Address
Ohri Manu (Reporting) CIK: 0001424683 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40023 | Film No.: 23574628